Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleBelzutifan versus Everolimus in Advanced Kidney Cancer: A Commentary on LITESPARK-005 Trial from ESMO 2023.AuthorsGulati, Shuchi; Nery Lara, PrimoPublicationKidney Cancer (2468-4562), 2024, Vol 8, Issue 1, p23ISSN2468-4562Publication typeArticleDOI10.3233/KCA-230024